The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on

Y Liao1, R S Cooper, D L McGee

  • 1Department of Preventive Medicine and Epidemiology, Loyola University Medical Center, Maywood, Ill 60153, USA.

JAMA
|May 24, 1995
PubMed

Insights

Left ventricular hypertrophy (LVH) significantly impacts survival more than coronary artery disease severity in black patients. This finding highlights LVH as a critical, independent risk factor for adverse outcomes in heart disease.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Clinical Medicine

Background:

  • Left ventricular hypertrophy (LVH) is a common cardiac adaptation.
  • Its prognostic significance relative to coronary artery disease (CAD) severity requires further elucidation.
  • Understanding these factors is crucial for managing cardiovascular risk, particularly in specific populations.

Purpose of the Study:

  • To compare the impact of echocardiographically determined LVH on survival.
  • To assess LVH's effect against the number of stenosed coronary vessels and left ventricular systolic dysfunction.
  • To evaluate LVH as an independent predictor of mortality in a cohort of black patients.

Main Methods:

  • A cohort study was conducted using a consecutive sample from a hospital registry.
  • 1089 black patients underwent coronary angiography and echocardiography.
  • Mean follow-up was 5 years, with analysis including multivariate models.

Main Results:

  • LVH was detected in 50% of patients.
  • LVH conferred a relative risk (RR) of 2.4 for mortality, exceeding that of multivessel disease (RR 1.6) and ventricular dysfunction (RR 2.0).
  • LVH independently accounted for 37% of deaths in the cohort, significantly higher than other factors.

Conclusions:

  • Left ventricular hypertrophy is a stronger predictor of mortality than traditional measures of coronary disease severity.
  • The high prevalence and potent risk associated with LVH contribute significantly to adverse survival rates in black patients with heart disease.
  • LVH may explain a substantial portion of the observed black-white disparities in cardiovascular outcomes.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...